Title(s):
NRG-GI004/SWOG-S1610. Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
Investigator(s): Judy Tsai, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
A021806. A phase III trial of perioperative versus adjuvant chemotherapy for resectable pancreatic cancer
Investigator(s): Judy Tsai, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GI008 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Investigator(s): Judy Tsai, MD
Contact Information: McDowell Cancer Research 330.344.6348
